On Monday, Emergent Biosolutions Inc (NYSE: EBS) was 8.06% up from the session before settling in for the closing price of $11.41. A 52-week range for EBS has been $4.02 – $13.41.
When this article was written, the company’s average yearly earnings per share was at 836.96%. With a float of $50.42 million, this company’s outstanding shares have now reached $52.70 million.
Emergent Biosolutions Inc (EBS) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Emergent Biosolutions Inc stocks. The insider ownership of Emergent Biosolutions Inc is 4.00%, while institutional ownership is 79.63%. The most recent insider transaction that took place on Dec 05 ’25, was worth 263,077. In this transaction Director of this company sold 21,984 shares at a rate of $11.97, taking the stock ownership to the 98,417 shares. Before that another transaction happened on Dec 05 ’25, when Company’s Director proposed sale 32,848 for $11.94, making the entire transaction worth $392,335.
Emergent Biosolutions Inc (EBS) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.05 earnings per share (EPS) during the time that was better than consensus figure (set at -0.5) by 0.55. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.97 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 836.96% per share during the next fiscal year.
Emergent Biosolutions Inc (NYSE: EBS) Trading Performance Indicators
You can see what Emergent Biosolutions Inc (EBS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.82. Likewise, its price to free cash flow for the trailing twelve months is 462.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.29, a number that is poised to hit 0.38 in the next quarter and is forecasted to reach -0.45 in one year’s time.
Technical Analysis of Emergent Biosolutions Inc (EBS)
Emergent Biosolutions Inc (NYSE: EBS) saw its 5-day average volume 0.81 million, a negative change from its year-to-date volume of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 68.13%.
During the past 100 days, Emergent Biosolutions Inc’s (EBS) raw stochastic average was set at 86.15%, which indicates a significant decrease from 92.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.50 in the past 14 days, which was lower than the 0.54 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.44, while its 200-day Moving Average is $7.60. Nevertheless, the first resistance level for the watch stands at $12.74 in the near term. At $13.14, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.82. If the price goes on to break the first support level at $11.65, it is likely to go to the next support level at $10.97. The third support level lies at $10.57 if the price breaches the second support level.
Emergent Biosolutions Inc (NYSE: EBS) Key Stats
There are 52,520K outstanding shares of the company, which has a market capitalization of 647.57 million. As of now, sales total 1,044 M while income totals -190,600 K. Its latest quarter income was 231,100 K while its last quarter net income were 51,200 K.
